GlassScriptPhysician profile
Stephen K Reed
NPI 1053381764
$2,616.55
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,030 · 2020: $62.41 · 2021: $508 · 2022: $588 · 2023: $336 · 2024: $92.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $428.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $740.08 | 2019 | |
| Abbott Laboratories | $679.51 | 2021-2024 | Cardiomems, Xience Sierra |
| Astrazeneca Pharmaceuticals LP | $479.00 | 2019-2023 | Brilinta, Farxiga |
| Angiodynamics, INC. | $182.46 | 2023-2024 | Auryon Laser System 100-120 Vac |
| Biotronik INC. | $80.99 | 2019 | |
| Shockwave Medical, INC | $70.69 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $60.50 | 2022 | |
| Merck Sharp & Dohme LLC | $50.99 | 2022-2023 | Verquvo |
| Cardiovascular Systems INC. | $42.19 | 2021-2023 | |
| Boston Scientific Corporation | $32.80 | 2021 | |
| Sanofi-Aventis U.S. LLC | $28.60 | 2019 | |
| Janssen Pharmaceuticals, INC | $27.74 | 2019 | |
| Terumo Medical Corporation | $26.87 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $25.92 | 2019 | |
| Werfen USA LLC | $19.90 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $14.56 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $14.53 | 2019 | |
| Pfizer INC. | $13.22 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.07 | 2020-2022 | |
| Amarin Pharma, INC. | $12.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Reed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.